August 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said its consolidated net profit rose to 29.9 million levs ($10.4 million/9.3 million euro) in the first half of 2017, from 26.3 million levs in the same period of 2016.